NEW YORK (GenomeWeb News) – Cellectis Group today announced that its stem cell business unit Ectycell has merged with Cellectis bioresearch.

Cellectis Group also announced a €3.5 million ($4.1 million) capital increase into Cellectis bioresearch, which was subscribed for by French financial organization Caisse des Depots.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.